ViroPharma lines up another orphan drug developer to acquire
ViroPharma (NASDAQ:VPHM) has entered into an exclusive option to acquire Meritage Pharma, a San Diego, California-based company developing an orphan drug, in a deal valued at more than $69 million. Meritage is focused on using oral budesonide suspension as a treatment for eosinophilic esophagitis, a chronic inflammatory disorder of the esophagus. Eosinophilic esophagitis is a […]